• Corpus ID: 21839155

The Role of Consumer Copayments for Health Care : Lessons from the RAND Health Insurance Experiment and Beyond

  title={The Role of Consumer Copayments for Health Care : Lessons from the RAND Health Insurance Experiment and Beyond},
  author={Jonathan H Gruber and Larry Levitt and Emmett B. Keeler and Willard G. Manning},

Tables from this paper

Effects of Contribution Co- Payments on Health Care and Health Financing in the German Health Care System

The effect of additional payments on the quality of care and efficiency is examined by considering various literature sources and the current co-payment reforms even lead to increased moral hazard behavior.

Does Preventive Care Reduce Usage of Curative Services ?

Existing research o¤ers somewhat mixed evidence on whether preventive care leads to reductions in usage of curative services. But do those …ndings re‡ect the somewhat limited dynamic considerations

Economic Evaluations of State Policies

This dissertation examines the effect of privatizing retail liquor sales and distribution on household-level alcohol purchases in Washington State by type of alcohol, using data from the Nielsen Consumer Panel Dataset and finds that privatization of liquor is associated with modest increases in liquor, beer, and ethanol purchases.

Out-of-pocket payments and community-wide health outcomes: an examination of influenza vaccination subsidies in Japan

It is found that payment reductions are negatively correlated with the number of weeks with a high influenza alert in that region, although the correlation varied across years, and reduced out-of-pocket payments contributes to the effective control of severe influenza epidemics.

Income-related patient cost-sharing: Simulation for prescription drugs under Medicare

It is found that varying patient costsharing rates with patient income in the Medicare prescription drug program can reduce the severity of two problems: high percent-of-income burdens, and unequal medication due to income.

The Unintended Cost of High Cost Sharing in Medicare-Assessing Consequences for Patients and Options for Policy.

  • E. Roberts
  • Medicine, Political Science
    JAMA health forum
  • 2021
One of the study’s most striking findings is how affordability burdens were concentrated among medically and socially vulnerable beneficiaries, and it is reported that Medicare includes substantial patient cost sharing, and traditional Medicare does not cap out-of-pocket spending, leaving beneficiaries exposed to potentially thousands of dollars of out- of-pocket costs.

Impact of Urban-Rural Health Insurance Integration on Health Care: Evidence from Rural China

It is found that the integration significantly increases the middle-aged and older rural residents' inpatient care utilization and this positive effect is particularly salient in poor areas, and the positive policy effect is attributed to enhanced health insurance benefits.

The Design of the RAND Health Insurance Experiment: A Retrospective

The design of the RAND Health Insurance Experiment is described, paying particular attention to the choice of arms, and how the results apply today, 4 decades after the Experiment was conducted.

Factors Influencing Depression: Comparison between Elders Living Alone and Elders Not Living Alone

The results of this study show that factors affecting depression are different according to the elders’ residence type, and it is necessary to establish different strategies according to their residence type to prevent depression in elderly people.



Health Insurance Status, Cost-Related Medication Underuse, and Outcomes Among Diabetes Patients in Three Systems of Care

Many patients with diabetes use less of their medication than prescribed because of the cost, and those reporting cost-related adherence problems have poorer health, although the VA’s drug coverage may protect patients from this increased risk.

www.kff.org Additional copies of this publication (#7566) are available on the Kaiser Family Foundation’s website at www.kff.org

  • 2000

Free for All: Lessons from the RAND Health Insurance Experiment

The results of the RAND Health Insurance Experiment are important in the debates on access to and financing of health services, and direct charges to patients. The study randomly assigned people in

Impact of the Cost of Prescription Drugs on Clinical Outcomes in Indigent Patients with Heart Disease

To measure the impact that economic relief for prescription drugs to indigent patients with cardiovascular disease has on indicators of disease control, a large number of patients with the disease have received financial assistance from the government.

Sources of health insurance and characteristics of the uninsured: analysis of the March 2005 Current Population Survey.

This paper provides historic data through 2004 on the number and percentage of nonelderly individuals with and without health insurance and highlights characteristics that typically indicate whether an individual is insured.

The Health Effects of Restricting Prescription Medication Use Because of Cost

Cost-related medication restriction among middle-aged and elderly Americans is associated with an increased risk of a subsequent decline in their self-reported health status, and among those with preexisting cardiovascular disease with higher rates of angina and nonfatal heart attacks or strokes.

The Effect of Office Visit Copayments on Utilization in a Health Maintenance Organization

The introduction of a $5 copayments for office visits resulted in a 10.9% decrease in primary care visits and a 3.3% drop in specialty care visits, and the copayment effect was immediate and did not diminish over the 12-month study period.

A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.

Efforts focusing on improving quality of care by identifying untreated patients or by enhancing compliance can lead to appropriately increased drug costs, although perhaps with reduced overall medical expenditures, while mechanisms implemented to constrain drug costs raise concerns regarding missed opportunities to enhance clinical outcomes, and the possibility of higher medical expenditures.

Two Wrongs Do Not Make a Right

  • Jason Furman
  • Economics, Political Science
    National Tax Journal
  • 2006
This paper analyzes proposals to remedy tax-induced distortions in health care by using new tax incentives and retaining all of the existing distortionary tax incentives. In the process of remedying

Adverse events associated with prescription drug cost-sharing among poor and elderly persons.

Increased cost-sharing for prescription drugs in elderly persons and welfare recipients was followed by reductions in use of essential drugs and a higher rate of serious adverse events and ED visits associated with these reductions.